Pharmacoeconomic Guideline for Malaysia (2nd Edition)

These guidelines aimed to encourage the production of timely, reliable, consistent and relevant pharmacoeconomic evaluations in the Malaysian healthcare system. They are intended for use by researchers, pharmaceutical companies, health economists, health professionals and all those who are involved in the conduct or use of pharmacoeconomic evaluations and budget impact analyses in Malaysia including for the purpose of submission of dossier for medicine listing into the Ministry of Health Medicines Formulary (MOHMF).